Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Preclinical Preclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
PreclinicalPreclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Diversity
Trends and Challenges Blog Series-Growing Complexity of Conducting Oncology Trials Blog The Growing Complexity of Conducting Oncology Trials Changing regulations, challenging study designs, and globalization Early-phase trial designs are becoming more complex following Read Now Graphic of San Antonio Breast Cancer Symposium with the words Highlights '24 Blog Highlights from the San Antonio Breast Cancer Symposium Celebrating new therapies, addressing challenges, and committing to patient advocacy I was thrilled to attend Read Now A smiling Keya Watkins gesturing at a podium at Clinical Trials in Oncology. Blog Navigating the Changing Landscape of Clinical Trials Takeaways from the Clinical Trials in Oncology East Coast I was thrilled to recently chair Read Now Article Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now Case Study Rapid Report on Rare Disease Epidemiology Medical writing and RWE expert staff increased operational efficiency Diversity in clinical trials has gained Read Now Article Underrepresented and Unsung, Disabled People Strive for Inclusion in Biopharma About one in four Americans live with some type of disability, according to the Centers for Disease Read Now